Table 1 Demographic characteristics of 3331 PLHIV receiving second-line antiretroviral therapy
Variables Total N=3331 Death N=508 Follow up (person-years) Follow up (person-years) Mortality(/100 person years)
Sex
Female 1600 (48%) 218(42.91%) 218(42.91%) 14234 1.53
Male 1731 (52%) 290(57.09%) 290(57.09%) 12754 2.27
Age (year)
<40 646 (19.4%) 65 (12.80%) 65 (12.80%) 5408 1.20
40-50 1749 (52.5%) 223 (43.90%) 223 (43.90%) 14426 1.55
50-60 936 (28.1%) 220 (43.31%) 220 (43.31%) 7154 3.08
Marital Status
Married 2461 (73.9%) 342 (67.32%) 342 (67.32%) 20095 1.70
Sig/window 870 (26.1%) 166 (32.68%) 166 (32.68%) 6893 2.41
Educational Status
≤6years 1978 (59.4%) 324 (63.78%) 324 (63.78%) 15746 2.06
>6years 1353 (40.6%) 184 (36.22%) 184 (36.22%) 11242 1.64
HIV transmission mode
Others 681 (20.4%) 93 (18.31%) 93 (18.31%) 5597 1.66
Plasma 2650 (79.6%) 415 (81.69%) 415 (81.69%) 21391 1.94
Time on HIV Positive (year) Time on HIV Positive (year)
<5 529 (8.53%) 91 (17.91%) 91 (17.91%) 4428 2.06
5-8 1800 (54.0%) 287 (56.50%) 287 (56.50%) 15006 1.91
>8 1002 (30.1%) 130 (25.59%) 130 (25.59%) 7554 1.72
Time on ART before Second-line (year) Time on ART before Second-line (year) Time on ART before Second-line (year) Time on ART before Second-line (year)
<3 817 (24.5%) 132(25.98%) 132(25.98%) 6523 2.02
3-6 1098 (33.0%) 155 (30.51%) 155 (30.51%) 9008 1.72
>6 1416 (42.5%) 221 (43.50%) 221 (43.50%) 11457 1.93
Chinese Medicine Therapy Chinese Medicine Therapy
No 2684 (80.6%) 430 (84.65%) 430 (84.65%) 21724 1.98
Yes 647 (19.4%) 78 (15.35%) 78 (15.35%) 5264 1.48
CD4+ Cell Count (cells/ μl) CD4+ Cell Count (cells/ μl)
<200 1005 (30.2%) 202 (39.76%) 202 (39.76%) 7853 2.57
200-350 1013 (30.4%) 157 (30.91%) 157 (30.91%) 8304 1.89
350-500 691 (20.7%) 79 (15.55%) 79 (15.55%) 5711 1.38
>500 622 (18.7%) 70 (13.78%) 70 (13.78%) 5120 1.37
Anemia
Unclear 1522(45.7%) 250(49.21%) 250(49.21%) 12039 2.08
No 1426 (42.8%) 197 (38.78%) 197 (38.78%) 11853 1.66
Yes 383 (11.5%) 61 (12.01%) 61 (12.01%) 3096 1.97
Liver injury
Unclear 1002 (30.1%) 163 (32.9%) 163 (32.9%) 7727 2.11
No 2043 (61.3%) 288 (56.69%) 288 (56.69%) 17014 1.69
Yes 286 (8.59%) 57 (11.22%) 57 (11.22%) 2247 2.54
Hyperlipidemia
Unclear 2177 (65.4%) 341 (67.13%) 341 (67.13%) 17567 1.94
No 854 (25.6%) 126 (24.80%) 126 (24.80%) 6899 1.83
Yes 300 (9.01%) 41 (8.07%) 41 (8.07%) 2522 1.63